Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David Hay

Showing results (41-50 of 42) with videos related to

Pageof 5
Sort By:
You have reached the last page of results.This site can display upto 42 results.
Gene Therapy|May 5, 2022
HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survivalSaqlain Suleman, Annette Payne, Johnathan Bowden, et al.
Gene Therapy|July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicitySaqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
Pageof 5

Showing results (41-50 of 42) with videos related to

Sort By:
Pageof 5
You have reached the last page of results.This site can display upto 42 results.
Gene Therapy|May 5, 2022
HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survivalSaqlain Suleman, Annette Payne, Johnathan Bowden, et al.
Gene Therapy|July 15, 2025
<sup>h</sup>InGeTox: a human-based in vitro platform to evaluate lentivirus/host interactions that contribute to genotoxicitySaqlain Suleman, Sharmin Alhaque, Andrew Guo, et al.
Pageof 5